238 related articles for article (PubMed ID: 35385892)
1. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review.
Agraib LM; Yamani MI; Rayyan YM; Abu-Sneineh AT; Tamimi TA; Tayyem RF
Drug Metab Pers Ther; 2021 Aug; 37(1):7-19. PubMed ID: 35385892
[TBL] [Abstract][Full Text] [Related]
2. The probiotic supplementation role in improving the immune system among people with ulcerative colitis: a narrative review.
Agraib LM; Yamani MI; Rayyan YM; Abu-Sneineh AT; Tamimi TA; Tayyem RF
Drug Metab Pers Ther; 2021 Aug; ():. PubMed ID: 34428363
[TBL] [Abstract][Full Text] [Related]
3. Probiotics and Their Use in Inflammatory Bowel Disease.
Amer M; Nadeem M; Nazir SUR; Fakhar M; Abid F; Ain QU; Asif E
Altern Ther Health Med; 2018 May; 24(3):16-23. PubMed ID: 29135456
[TBL] [Abstract][Full Text] [Related]
4. Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.
Coqueiro AY; Raizel R; Bonvini A; Tirapegui J; Rogero MM
Int J Food Sci Nutr; 2019 Feb; 70(1):20-29. PubMed ID: 29804478
[TBL] [Abstract][Full Text] [Related]
5. Probiotics: The scientific evidence in the context of inflammatory bowel disease.
Celiberto LS; Bedani R; Rossi EA; Cavallini DC
Crit Rev Food Sci Nutr; 2017 Jun; 57(9):1759-1768. PubMed ID: 25996176
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Probiotics in the Treatment of Inflammatory Bowel Disease (IBD)-A Critical Review.
Jakubczyk D; Leszczyńska K; Górska S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32630805
[TBL] [Abstract][Full Text] [Related]
7. Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection.
Cunningham-Rundles S; Ahrné S; Johann-Liang R; Abuav R; Dunn-Navarra AM; Grassey C; Bengmark S; Cervia JS
Nutrients; 2011 Dec; 3(12):1042-70. PubMed ID: 22292110
[TBL] [Abstract][Full Text] [Related]
8. Probiotics in the Treatment of Inflammatory Bowel Disease.
Guandalini S; Sansotta N
Adv Exp Med Biol; 2019; 1125():101-107. PubMed ID: 30632114
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into the role of probiotics in modulating immune cells in ulcerative colitis.
Guo N; Lv LL
Immun Inflamm Dis; 2023 Oct; 11(10):e1045. PubMed ID: 37904683
[TBL] [Abstract][Full Text] [Related]
10. A Mini Literature Review of Probiotics: Transforming Gastrointestinal Health Through Evidence-Based Insights.
Mohammed C; Fuego JP; Garcia KV; Jamil H; Rajesh RY; Escobar AS; Hassan MJ; Rai M
Cureus; 2024 Mar; 16(3):e57055. PubMed ID: 38681263
[TBL] [Abstract][Full Text] [Related]
11. Review of Saccharomyces boulardii as a treatment option in IBD.
Sivananthan K; Petersen AM
Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
[TBL] [Abstract][Full Text] [Related]
12. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
[TBL] [Abstract][Full Text] [Related]
13. Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive
Leccese G; Bibi A; Mazza S; Facciotti F; Caprioli F; Landini P; Paroni M
Cells; 2020 Aug; 9(8):. PubMed ID: 32752244
[TBL] [Abstract][Full Text] [Related]
14. The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials.
Saez-Lara MJ; Gomez-Llorente C; Plaza-Diaz J; Gil A
Biomed Res Int; 2015; 2015():505878. PubMed ID: 25793197
[TBL] [Abstract][Full Text] [Related]
15. Mucosal bacteria in ulcerative colitis.
Macfarlane S; Furrie E; Kennedy A; Cummings JH; Macfarlane GT
Br J Nutr; 2005 Apr; 93 Suppl 1():S67-72. PubMed ID: 15877898
[TBL] [Abstract][Full Text] [Related]
16. Probiotics for maintenance of remission in ulcerative colitis.
Iheozor-Ejiofor Z; Kaur L; Gordon M; Baines PA; Sinopoulou V; Akobeng AK
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD007443. PubMed ID: 32128794
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering.
Mishra J; Stubbs M; Kuang L; Vara N; Kumar P; Kumar N
Mediators Inflamm; 2022; 2022():9621668. PubMed ID: 35082553
[TBL] [Abstract][Full Text] [Related]
18. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.
Furrie E; Macfarlane S; Kennedy A; Cummings JH; Walsh SV; O'neil DA; Macfarlane GT
Gut; 2005 Feb; 54(2):242-9. PubMed ID: 15647189
[TBL] [Abstract][Full Text] [Related]
19. Beneficial role of the probiotic mixture Ultrabiotique on maintaining the integrity of intestinal mucosal barrier in DSS-induced experimental colitis.
Toumi R; Abdelouhab K; Rafa H; Soufli I; Raissi-Kerboua D; Djeraba Z; Touil-Boukoffa C
Immunopharmacol Immunotoxicol; 2013 Jun; 35(3):403-9. PubMed ID: 23638770
[TBL] [Abstract][Full Text] [Related]
20. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics.
Linskens RK; Huijsdens XW; Savelkoul PH; Vandenbroucke-Grauls CM; Meuwissen SG
Scand J Gastroenterol Suppl; 2001; (234):29-40. PubMed ID: 11768558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
